This document was published more than 2 years ago. The nature of the evidence may have changed.
How to cite this report: SBU. Aromatase inhibitors in the treatment of early ER-positive breast cancer in post-menopausal women. Stockholm: Swedish Council on Health Technology Assessment (SBU); 2014. SBU report no 2014-02 (in Swedish).
presents a comprehensive, systematic assessment of available scientific evidence. The certainty of the evidence for each finding is systematically reviewed and graded. Full assessments include economic, social, and ethical impact analyses.
SBU assessments are performed by a team of leading professional practitioners and academics, patient/user representatives and SBU staff. Prior to approval and publication, assessments are reviewed by independent experts, SBU’s Scientific Advisory Committees and Board of Directors.